Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Next-Generation Antisense Oligonucleotide of TGF-β2 Enhances T Cell-Mediated Anticancer Efficacy of Anti-PD-1 Therapy in a Humanized Mouse Model of Immune-Excluded Melanoma.
Cancers (Basel). 2022 Oct 25;14(21):5220. doi: 10.3390/cancers14215220.
Cancers (Basel). 2022.
PMID: 36358638
Free PMC article.
Targeting transforming growth factor-β2 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancer.
Lee HK, Ji HJ, Shin SK, Koo J, Kim TH, Kim CW, Seong YH, Park JE, Choi KC.
Lee HK, et al.
Cancer Immunol Immunother. 2022 Sep;71(9):2213-2226. doi: 10.1007/s00262-022-03157-w. Epub 2022 Jan 31.
Cancer Immunol Immunother. 2022.
PMID: 35099588
Free PMC article.
Item in Clipboard
Potential Roles of Iridoid Glycosides and Their Underlying Mechanisms against Diverse Cancer Growth and Metastasis: Do They Have an Inhibitory Effect on Cancer Progression?
Kim CW, Choi KC.
Kim CW, et al.
Nutrients. 2021 Aug 26;13(9):2974. doi: 10.3390/nu13092974.
Nutrients. 2021.
PMID: 34578851
Free PMC article.
Review.
Item in Clipboard
Cite
Cite